Hengrui Pharma's Class 1 Biologic SHR-7590 Receives Dual IND Acceptance from CDE on Same Day
May 20, 2026 15:07
CST Updated
16:48
Hengrui Pharma
Innovative and High-Quality Pharmaceutical Developer
Innovative and High-Quality Pharmaceutical Developer